My provider, Kristi, made me feel supported from day one, even when I experienced side effects early on
Cindy Jurgens Medical Assistant Cindy Dean APRN, CNM Provider Erin Jarrett Clinic Director We take a full-body approach to healthaddressing metabolism, hormones, energy, and overall wellness
Choline is involved in early development of the brain, gene expression, cell membrane signaling, and brain metabolism

Proposed Escalation Strategy A theoretical cagrilintide and retatrutide combination protocol might follow this gradual escalation approach: Weeks 1-4: Foundation Phase Cagrilintide: 0.6 mg weekly Retatrutide: 2 mg weekly Focus: Establishing tolerance to both compounds Monitoring: Gastrointestinal effects, appetite changes Weeks 5-8: Escalation Phase Cagrilintide: 1.2 mg weekly Retatrutide: 4 mg weekly Focus: Increasing receptor activation Monitoring: Weight changes, metabolic markers Weeks 9-12: Optimization Phase Cagrilintide: 2.4 mg weekly Retatrutide: 8 mg weekly Focus: Approaching therapeutic targets Monitoring: Comprehensive metabolic assessment Weeks 13+: Maintenance Phase Cagrilintide: 3.0-4.5 mg weekly Retatrutide: 8-12 mg weekly Focus: Sustained metabolic effects Monitoring: Long-term safety and efficacy This graduated approach mirrors the successful strategies used in cagrilintide 10mg research protocols, where slow escalation minimizes side effects while building therapeutic benefit

This peptide chain can be cleaved at different sites to produce various biologically active small peptide segments, one of which becomes glucagon
This is essentially a sophisticated freeze-drying process where the peptide, in a water-based solution, is frozen and then placed under a vacuum